Guangzhou AI Simai Biomedical Technology Co., Ltd.
爱思迈
Guangzhou AI Simai Biomedical Technology Co., Ltd.
Biotech/Healthcare
Guangzhou ExMab is a global innovative biopharmaceutical company focused on the development and industrialization of bispecific antibody drugs. ExMab has filed multiple invention patents; its proprietary ExMab® platform technology patents have been granted in China, the US, Japan, Canada, South…
Latest round: Pre Series B (2021)
Source: ChinaBulls — chinabulls.com
Last updated 2021-08-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.